What is Buerger's disease, a condition affecting young to middle-aged men who are heavy smokers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Buerger's Disease (Thromboangiitis Obliterans)

Buerger's disease is a nonatherosclerotic inflammatory vasculitis that causes segmental thrombotic occlusions of small- and medium-sized arteries and veins in the distal extremities, almost exclusively affecting young tobacco smokers under age 50. 1

Pathophysiology and Demographics

  • This is an inflammatory occlusive vasculitis that behaves like an arterial obliterative and thrombotic process, affecting arteries of all sizes as well as superficial veins. 1

  • The disease predominantly affects young male tobacco smokers, typically less than 45-50 years old at onset, with a near-universal finding of heavy tobacco use. 1

  • The incidence is approximately 12.6 per 100,000 in North America. 1

  • Males are affected more commonly than females (55 males to 3 females in one surgical series). 2

Clinical Manifestations

Early Symptoms

  • Migratory superficial thrombophlebitis is a common early finding, characterized by recurrent episodes affecting superficial veins of extremities. 1

  • Paresthesias, including numbness or tingling in affected digits, occur early in the disease course. 1

Progressive Ischemic Symptoms

  • Intermittent claudication develops in 23% of patients, with progressive worsening of exercise-induced pain. 1, 2

  • Rest pain occurs in 13% of patients, manifesting as severe pain in affected extremities even without activity. 1, 2

  • Ischemic ulcers or frank gangrene of the toes or fingers develop in 64% of patients, representing advanced disease. 1, 2

  • Upper limb involvement, including cyanosis, paleness, and gangrene, is obvious in 84% of patients. 2

Disease Distribution

  • While classically affecting distal extremities, arterial lesions can extend to the femoral arteries in 25% of cases, to the iliac arteries in 8%, and to the abdominal aorta and/or visceral arteries in 6% of cases. 2

Diagnostic Criteria

The diagnosis is based on Shionoya's clinical diagnostic criteria, which must all be fulfilled: 2, 3

  1. History of smoking (or tobacco use)
  2. Onset before age 50 years
  3. Presence of infrapopliteal arterial occlusions
  4. Either upper limb involvement or phlebitis migrans
  5. Absence of atherosclerotic risk factors other than smoking

Imaging Characteristics

  • Arteriography classically demonstrates "corkscrew," "spider legs," or "tree roots" collateral vessels representing pathologically dilated vasa vasorum. 1, 4

  • These angiographic findings are suggestive but not pathognomonic and should not be used alone for diagnosis. 4, 3

Treatment

Absolute Tobacco Cessation (Primary Treatment)

Complete and permanent cessation of all tobacco use is the only definitive treatment that halts disease progression and prevents amputation. 4

  • Continued smoking is directly linked to disease advancement. 5

  • Each clinician should advise patients to stop smoking and offer comprehensive cessation interventions including behavior modification therapy, nicotine replacement therapy, or bupropion. 4

  • Critical caveat: Substitution of smokeless tobacco for cigarettes does not prevent limb loss and can lead to progressive disease requiring bilateral below-knee amputations. 6

Medical Management

  • Initiate antiplatelet therapy to reduce risk of myocardial infarction, stroke, or vascular death. 4

  • Infusion of iloprost has demonstrated some efficacy in patients with ischemic lesions. 7

Conservative Management

  • Claudicants should be encouraged to walk, whereas patients with critical ischemia should be admitted for bed rest in the hospital. 3

  • Local wound care is the main component of therapeutic management for patients with ischemic lesions. 7

Surgical Options

  • Bypass grafting is seldom an option, as the location of lesions distally leaves little to bypass because of lack of target vessels. 3

  • When performed, femorodistal bypasses show suboptimal patency rates but satisfactory limb salvage rates, as patent grafts even over a short period allow healing of ulcers. 3

  • Lumbar sympathectomy was performed in 33 patients and thoracic sympathectomy in 8 patients in one surgical series. 2

Amputation Rates

  • Minor limb amputations are required in 20% of patients, and major limb amputations in 4% of patients. 2

Associated Conditions

  • More than half of Buerger's disease patients suffer from severe periodontitis (grades B, C, or D), suggesting that improvement of periodontal care could potentially improve clinical symptoms. 2

References

Guideline

Clinical Manifestations and Diagnosis of Buerger's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnostic criteria and treatment of Buerger's disease: a review.

The international journal of lower extremity wounds, 2006

Guideline

Treatment of Buerger's Disease (Thromboangiitis Obliterans)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cardiovascular Risk Assessment and Management in High-Risk Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[THROMBOANGIITIS OBLITERANS (BUERGER'S DISEASE)].

La Revue du praticien, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.